{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:55:49Z","timestamp":1791006949706,"version":"4.1.0"},"reference-count":26,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0532","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:12:27Z","timestamp":1790892747000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Pancreatic Cancer Complicated by Active Pulmonary Tuberculosis Successfully Managed through a Multidisciplinary Treatment Strategy"],"prefix":"10.70352","volume":"12","author":[{"given":"Kenta","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-3716","authenticated-orcid":false,"given":"Masaya","family":"Suenaga","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Umemura","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Hada","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hakamata","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-7474","authenticated-orcid":false,"given":"Yasuhiro","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Nagoya Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","unstructured":"1) World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment and care. Geneva: World Health Organization; 2025."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dobler CC, Cheung K, Nguyen J, et al. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J 2017; 50: 1700157.","DOI":"10.1183\/13993003.00157-2017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Okusaka T, Nakamura M, Yoshida M, et al. Clinical practice guidelines for pancreatic cancer 2022 from the Japan Pancreas Society: a synopsis. Int J Clin Oncol 2023; 28: 493\u2013511.","DOI":"10.1007\/s10147-023-02317-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hirashima T, Tamura Y, Han Y, et al. Efficacy and safety of concurrent anti-cancer and anti-tuberculosis chemotherapy in cancer patients with active <i>Mycobacterium tuberculosis<\/i>: a retrospective study. BMC Cancer 2018; 18: 975.","DOI":"10.1186\/s12885-018-4889-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 2018; 18: 2\u201311.","DOI":"10.1016\/j.pan.2017.11.011"},{"key":"6","unstructured":"6) The Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis. JSTB guideline for the diagnosis and treatment of tuberculosis 2024. Tokyo: Nankodo; 2024."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691\u2013703.","DOI":"10.1056\/NEJMoa1304369"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228\u201347.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nakao A. Isolated pancreatectomy using mesenteric approach. J Hepatobiliary Pancreat Sci 2022; 29: 293\u2013300.","DOI":"10.1002\/jhbp.1092"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ishida M, Fujii T, Kishiwada M, et al. Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: eighth edition. J Hepatobiliary Pancreat Sci 2024; 31: 755\u201368.","DOI":"10.1002\/jhbp.12056"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 8th ed. Oxford: Wiley-Blackwell; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Cheng MP, Chakra CNA, Yansouni CP, et al. Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis. Clin Infect Dis 2017; 64: 635\u201344.","DOI":"10.1093\/cid\/ciw838"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Diefenbach-Elstob T, Tabrizi S, Rivest P, et al. Risk of TB disease in individuals with cancer. IJTLD Open 2025; 2: 45\u201352.","DOI":"10.5588\/ijtldopen.24.0440"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cheon J, Kim C, Park EJ, et al. Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea. J Thorac Dis 2020; 12: 4950\u20139.","DOI":"10.21037\/jtd.2020.02.50"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Panic N, Maetzel H, Bulajic M, et al. Pancreatic tuberculosis: a systematic review of symptoms, diagnosis and treatment. United European Gastroenterol J 2020; 8: 396\u2013402.","DOI":"10.1177\/2050640620902353"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zheng ZJ, Zhang H, Xiang GM, et al. Coexistence of pancreatic carcinoma and pancreatic tuberculosis: case report. Gut Liver 2011; 5: 536\u20138.","DOI":"10.5009\/gnl.2011.5.4.536"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hong W, Zhang L, Yu Z, et al. Intestinal obstruction following antituberculosis therapy in a patient with pancreatic carcinoma and pulmonary tuberculosis: a case report. J Med Case Rep 2024; 18: 495.","DOI":"10.1186\/s13256-024-04849-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nair CK, Avaronnan M, Shenoy PK, et al. Impact of active tuberculosis on treatment decisions in cancer. Curr Probl Cancer 2021; 45: 100643.","DOI":"10.1016\/j.currproblcancer.2020.100643"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kim DK, Lee SW, Yoo CG, et al. Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy. Chest 2005; 128: 2218\u201322.","DOI":"10.1378\/chest.128.4.2218"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Zhou ZJ, Xie HY, Bertolaccini L, et al. Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review. Transl Lung Cancer Res 2025; 14: 2272\u201380.","DOI":"10.21037\/tlcr-2025-450"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chastain DB, Spradlin M, Ahmad H, et al. Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults. Clin Infect Dis 2024; 78: e37\u201356.","DOI":"10.1093\/cid\/ciad474"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63: e147\u201395.","DOI":"10.1093\/cid\/ciw376"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819\u201350.","DOI":"10.2165\/00003088-200342090-00003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Bates A, West MA, Jack S, et al. Preparing for and Not Waiting for Surgery. Curr Oncol 2024; 31: 629\u201348.","DOI":"10.3390\/curroncol31020046"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Unno M, Motoi F, Matsuyama Y, et al. Neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer: results of the randomized phase II\/III prep-02\/JSAP05 trial. Ann Surg 2026; 283: 57\u201364.","DOI":"10.1097\/SLA.0000000000006730"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ohba A, Ozaka M, Mizusawa J, et al. Modified fluorouracil, leucovorin, irinotecan, and oxaliplatin or S-1, irinotecan, and oxaliplatin versus nab-paclitaxel + gemcitabine in metastatic or recurrent pancreatic cancer (GENERATE, JCOG1611): a randomized, open-label, phase II\/III trial. J Clin Oncol 2025; 43: 3345\u201354.","DOI":"10.1200\/JCO.24.00936"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0532\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:49:04Z","timestamp":1791006544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0532\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0532","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0532"}}